-
Miranda Lambert Leads North Texans with Seven Grammy Nominations for 2027
-
DiDi Advances Robotaxi Operations in China with New R2 Vehicle and Expanded Safety Infrastructure
-
Smart Car Seats Tested: Do Sensors and Apps Actually Improve Safety?
-
XPENG Launches Two New Models in UK; Pony.ai Robotaxi Enters Pilot
-
NexCore and MetLife Investment Management Launch $1.3 Billion Senior Living Co-Investment Venture
-
Galway Metals Intersects 1.8 g/t Gold Over 25.0 Metres and 0.7 g/t Gold Over 66.0 Metres at Clarence Stream
-
RuffleButts + RuggedButts Featured in Hasbro's 2026 Holiday Gift Guide
-
KIDZ AI Announces Strategic Collaboration with Synestria to Optimize AI Infrastructure Performance
-
Brightline Interactive and TruWeather Solutions Sign MOU to Bring Weather Data into SpatialCore Physical AI Platform
-
Avino Announces Key Technical Appointment
-
HippoFi Achieves OTCID Market Designation, Opening a New Chapter of Commercial Growth
-
Gabriel Resources Provides Corporate and Financing Update
-
MedMira Receives U.S. FDA Breakthrough Device Designation for Its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
-
Pivotree Announces Third Quarter 2026 Results
-
Ur-Energy Commences Baseline Study Fieldwork; Nears Completion of Technical Report at Lost Soldier Uranium Project, Wyoming
-
ImageWorks Display Advances Whole-Store Solutions with a Re-Imagined Planniq Strong and Planniq Chill
-
Razavi Law Group Partners with Chapman University to Prepare the Next Generation of Attorneys
-
Broad Clinical Labs Drives Strong Digital Engagement by Connecting Customers with Published Research Through Bioz
-
PRAAMS AI Co-Investor Now Covers 400,000+ Global Instruments, With Responses From 3 Seconds, Cost From US$0.01, and Scalability to Millions of Users
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 17
-
Driving Global Innovation - GTDC Summit APJ Underscores Distribution's Transformative Power
-
Pilot-Founded Solara Global Jet Offers Charter, Leases and Air Cargo Nationwide and Overseas
-
How to Turn Your Garage into Usable Living Space
-
Glidewell Opens Applications for 2027 Guiding Leaders Cohorts in California and North Carolina
-
The Next Healthcare Story Worth Telling May Be About Someone You Know
-
NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox (Monkeypox)
-
Atlas Signal Initiates Coverage of High Roller Technologies: ROLR(TM) Prediction-Markets Platform Goes Live on iPhone for U.S. Customers
-
Join Nord Precious Metals' Live Investor Webinar: Advancing Silver Production and High-Grade Exploration in Ontario
-
Executing Our Plan, Increasing Equity and Reducing Liabilities in Order to Build Long-Term Value
-
Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment
-
Nexscient Reports Third Quarter 2026 Results; Revenue Rises Sequentially as Gross Margin Expands to Over 40%
-
Viking Global Technologies Announces Expansion of Grid Protection Technology Pilot with Another Major U.S. Electric Utility
-
TRNR Reports Record Q3 2026 Results, Driven by 66% Revenue Growth; M&A Pipeline Grows Significantly
-
Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program
-
FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at Osaka Major
-
Waste Energy to Host Shareholder Update Today at 4:30 PM EST; Management to Discuss WE #1 Commissioning, Revenue Opportunities and Growth Strategy
-
Klique Joins Lenovo AI Innovators, Bringing Its Enterprise AI Control Plane to Lenovo Hybrid AI Factory
-
Miami Allstars FC have Applied to Compete in the Women's Premier Soccer League, with the Club Targeting a 2027 or 2028 Debut in North Miami, Florida
-
Valion Bio Reports Completion of 200-Liter Entolimod Production Run; Material Supplying Ongoing AFRRI Study
-
International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital
-
Tectonic Metals Completes Record Drill Program at Flat, Advances Five Pillars of Growth Toward Major 2027 Milestones
-
BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027
-
Three Inaugural CombatX Champions Crowned at BRAVE CF Road to BRAVE Event in Hungary
-
French Economy Shrinks 0.1% as Consumer Confidence Slumps
-
China's Factory Activity Contracts as Export Orders Weaken
-
Wall Street Ends Turbulent Week Higher Despite Inflation and AI Jitters
-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Luxury Skincare Brand Faces Backlash Over Futurist Manifesto Aesthetic
VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers
Multi-disciplinary cancer center joins VieCure's intelligent care ecosystem, bringing advanced precision oncology capabilities to the Pacific Northwest
DENVER, CO / ACCESS Newswire / August 5, 2025 / VieCure Inc., a leading provider of intelligence platforms that make precision oncology care accessible for community-based practices, today announced that Summit Cancer Centers has joined the VieCure network. The Spokane, Wash.-based multi-disciplinary cancer center will implement VieCure's Halo Intelligence™ platform to enhance precision oncology capabilities and streamline clinical workflows for patients across the Pacific Northwest.
Summit Cancer Centers, with more than 25 years of experience serving the region, provides comprehensive cancer care including medical oncology, radiation oncology, surgical oncology, imaging, laboratory services, and interventional radiology. The practices are recognized as innovative community cancer centers offering radioligand therapy. The centers are also leading sites for phase 1 clinical trials.
Through the integration of VieCure's Halo Intelligence platform, Summit providers across Spokane and the surrounding region will gain access to real-time clinical decision support and enhanced patient care coordination powered by AI and data analytics capabilities. The platform's flexible approach will enable integration with Summit's existing systems and multiple data sources, reducing operational complexity while enhancing the precision and speed of clinical decision-making.
"We built the Halo Intelligence platform to be the most robust operating system for oncology care," said Michael Power, Chief Executive Officer of VieCure. "Summit Cancer Centers exemplifies the kind of innovative, patient-focused practice that drives our mission to make precision oncology practical for every provider, in every setting. Summit's commitment to offering specialized treatments like radioligand therapy and early-phase clinical trials in a community setting perfectly aligns with our vision of making high-quality cancer care accessible everywhere."
This collaboration addresses the growing complexity of oncology data and the need for more sophisticated tools to manage molecular testing, treatment guidelines, and compliance requirements. VieCure's platform will enable Summit's practitioners to better integrate disparate data sources and provide more targeted, personalized treatment recommendations for their patients.
"The future of oncology lies in precision medicine. To deliver excellent care, we need access to comprehensive data and analytical tools," said Arvind Chaudhry, MD, PhD, Medical Oncologist and Director of Summit Cancer Centers. "Many patients prefer to receive treatment close to home rather than traveling to large urban centers. VieCure's platform will help us continue providing the personalized care our patients deserve while maintaining the community-focused approach that sets us apart."
Beyond the technology platform, VieCure provides comprehensive implementation services and ongoing support. "We're implementing Halo Intelligence with Summit in just 60 days, which is virtually unheard of in our industry," said Carlos Castilleja, Executive Vice President of Operations and Client Success at VieCure. "Our dedicated client success team has developed a proven methodology that accelerates deployment without compromising quality or disrupting care. This full-service approach ensures that practices can maximize the value of their investment while maintaining focus on the patient during the transition and beyond."
About VieCure
VieCure is the leading provider of next-generation intelligence platforms for community oncology care. Its Halo Intelligence platform is the first AI-enabled clinical decision support and smart electronic medical record platform to assist clinicians in managing a patient's personalized treatment plan throughout cancer diagnosis, therapy, and follow-up care. VieCure was launched in 2016, and its community cancer center network now includes more than 100 locations. For more information, please visit VieCure.com and connect with the company on LinkedIn.
VieCure, the VieCure logo, and Halo Intelligence are trademarks of VieCure Inc.
Media Contact
Andrew Noble
Media Relations
(415) 722-2129
[email protected]
SOURCE: VieCure
View the original press release on ACCESS Newswire
H.Thompson--AT